Genomics Flashcards

1
Q

amitryptyline metabolism pathway

A

2C19 activates it

2D6 deactivates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2D6 genotypes

A
  • normal = 1, 2

- non-functional = 3-8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

amitryptyline 2C19 recommendations

A
  • avoid in ultrarapid and poor metabolizers

- standard dose in extensive and intermediate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

amitryptyline 2D6 recommendations

A
  • avoid in ultrarapid and poor

- 25% reduction in intermediate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

simvastatin gene involved in metabolism

A

SLCO1B1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

simvastatin genotypes/phenotypes

A
  • TT = standard
  • TC = intermediate
  • CC = low function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

simvastatin dosing recommendations

A
  • TT = normal
  • TC = lower dose or alternative
  • CC = lower dose or alternative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

methotrexate metabolism by

A

SLC19A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

methotrexate mutation

A

SNP at SLC19A1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

methotrexate recommendations

A

no definitive recommendations

-higher risk of toxicity has been seen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clopidogrel metabolism

A

2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clopidogrel phenotypes

A
  • Ultra = 17
  • extensive = 1/1
  • intermediate = 1 and 2-8 or 17 and 2-8
  • poor = 2-8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

clopidogrel recommendations

A

any loss of function allele should get alternative therapy

-still use in ultra rapid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

bupropion metabolised by

A

2B6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

bupropion moderately inhibits

A

2D6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

gene related to smoking cessation in bupropion

17
Q

bupropion recommendations

A
  • loss of 2B6 may need other treatment

- ANKK1 AA or AG may have decreased response

18
Q

codeine metabolism

19
Q

codeine recommendations

A

-alternative in ultra rapid and poor

20
Q

aripiprazole metabolism

21
Q

aripiprazole recommendations

A
  • poor 2D6 = reduce dose by half

- poor 2D6 + 3A4 inhib = reduce to 1/4

22
Q

drugs to do HLA-B*5701 test for

A

abacavir

carbamazepine

23
Q

patients to do HLA testing when using allopurinol

24
Q

warfarin metabolism

25
normal VKORC1 genotypes
G | C
26
VKORC1 mutations
G > A | C > T
27
2C9 genotypes
1 - normal | 2,3 - reduced
28
warfarin recommendations
no specific, maybe use table
29
irinotecan mutation
UGT1A1*28
30
irinotecan recommendations
if UGT1A1*28 is present reduce dose by 30%
31
tamoxifen metabolism
*mainly activated 2D6* | some 2C9 and 3A4
32
tamoxifen recommendations
- avoid in poor - consider something else in intermediate - ultra rapid is fine
33
gene of interest in cetuximab and panitumumab
KRAS | if its not present then they won't work